🇺🇸 FDA
Patent

US 6265380

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

expired A61KA61K38/00A61P

Quick answer

US patent 6265380 (Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K38/00, A61P, A61P1/16, A61P31/12